Compass Pathways plc (Nasdaq: CMPS)

https://www.compasspathways.com

COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we are currently conducting a phase IIb clinical trial of psilocybin therapy for TRD, in 20 sites across Europe and North America. We are headquartered in London, UK, with offices in New York, USA. Our vision is a world of mental wellbeing. *

	Start	2020-08-01 renamed
	Group	Compass Pathways (Group)
	Predecessor	Compass Rx Ltd.
	Industry	psilocybin
	Person	Goldsmith, George (Compass Pathways 202004 CEO + Co-Founder)
	Person 2	Wilde, Lars Christian (Compass Pathways 202004 CBO + Co-Founder)

	Street	1 Ashley Road 3rd Floor
	City	WA14 2DT Altrincham, Cheshire
		Address record changed: 2020-12-02

Basic data	Employees	C: 51 to 100 (2020-12-31)
	Currency	USD
	Profit	-60,334,000 (2020-12-31)
	Cash	190,327,000 (2020-12-31)

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for Compass Pathways (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)